শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

ইঙ্গিত

Zipradon is an atypical antipsychotic. In choosing among treatments, prescribers should be aware of Zipradon's capacity to prolong the QT interval and may consider the use of other drugs first. Zipradon capsules are indicated for the treatment of schizophrenia in adults, for acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy, and for maintenance treatment of bipolar I disorder in adults as an adjunct to lithium or valproate.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Ziprasidone's action in the listed indications is thought to result from a combination of antagonism at dopamine type 2 (D2) and serotonin type 2 (5HT2) receptors. The drug binds with relatively high affinity to dopamine D2 and D3 receptors, serotonin 5HT2A, 5HT2C, 5HT1A, and 5HT1D receptors, and α1-adrenergic receptors (Ki values of 4.8, 7.2, 0.4, 1.3, 3.4, 2, and 10 nM, respectively), and with moderate affinity to the histamine H1 receptor (Ki=47 nM). It acts as an antagonist at the D2, 5HT2A, and 5HT1D receptors, and as an agonist at the 5HT1A receptor. Ziprasidone also inhibits synaptic reuptake of serotonin and norepinephrine. It showed no appreciable affinity for the other receptor and binding sites tested, including the cholinergic muscarinic receptor (IC50 greater than 1 µM).

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: Administer capsules by mouth with food, and do not open, crush, or chew them. For schizophrenia: begin at 20 mg twice daily. The daily dose may be adjusted up to 80 mg twice daily, with adjustments made no more often than every 2 days. Doses up to 100 mg twice daily have been shown to be safe and effective, but the lowest effective dose should always be used. For acute treatment of manic or mixed episodes of bipolar I disorder: begin at 40 mg twice daily, increasing to 60 mg or 80 mg twice daily on the second day of treatment. Further adjustments should be guided by tolerability and response, within a range of 40 mg to 80 mg twice daily. For maintenance treatment of bipolar I disorder as an add on to lithium or valproate: continue at the same dose at which the patient was originally stabilized, within a range of 40 mg to 80 mg twice daily. For acute treatment of agitation associated with schizophrenia, given by intramuscular injection: 10 mg to 20 mg as needed, up to a maximum of 40 mg per day. A 10 mg dose may be repeated every 2 hours, and a 20 mg dose may be repeated every 4 hours.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.

প্রধান পারস্পরিক ক্রিয়া

Checker →